19/10/2022
Mantra Pharma solidifies its position in the Canadian industry by launching M-Amoxi Clav
Quebec pharmaceutical company Mantra Pharma is pleased to announce the approval of the all-new M-Amoxi Clav (400 mg/57 mg per...
21/09/2022
Expansion continues with the launch of 6 products, including M-Apixaban
Since the beginning of 2022, Mantra Pharma has launched several new products, planning to offer no less than six new...
10/01/2021
Mantra Pharma opens its new distribution centre
It is with great pride that Mantra Pharma's Lévis team opened its new warehouse and business location The building already...